Larry Green, PhD

CEO at Ablexis, LLC

Larry is CEO and founder of Ablexis, and co-inventor of the AlivaMab® Mouse. He also serves as Chairman of the Board of AlivaMab Discovery Services. Larry has over a quarter century of experience in designing, creating and using transgenic mouse platforms for antibody drug discovery. Prior to founding Ablexis, he was a co-inventor of the XenoMouse® technology (Abgenix, Inc., acquired by Amgen, Inc. in 2006.) To date, the XenoMouse technology has yielded seven approved antibody drugs, securing its position as one of the most successful platforms for human antibody drug discovery. Larry is an inventor on over sixty US patents covering immunoglobulin transgenic mice, immunoglobulin transgene design and therapeutic antibodies.